Category:Clinical Biochemistry (POTE course)
Pages in category ‘Clinical Biochemistry (POTE course)’
The following 51 pages are in this category, out of 51 total.
0–9
- 1. Purpose of laboratory test requests (screening, diagnosis, differential-diagnosis, validation, monitoring).
- 2. Patient preparation before sampling. Proper method to carry out blood (venous, capillary) and urine collection. Type of tubes.
- 3. Reference values and ranges, specificity, sensitivity and predictive value of laboratory tests.
- 4. Interpretation of laboratory results. Biological and analytical factors influencing the results.
- 5. Bedside/point of care tests (POCT) and their informational value
- 6. Disorders of water and sodium homeostasis
- 7. Disorders of potassium balance
- 8. Laboratory findings in metabolic type changes of the acid/base balance
- 9. Laboratory findings in respiratory type changes of the acid/base balance
- 10. Laboratory approaches for the detection of disorders in calcium, magnesium and phosphate homeostasis
- 11. Clinical biochemistry of osteoporosis. Laboratory tests to assess joint and bone disorders.
- 12. Laboratory analysis of plasma proteins
- 13. Laboratory analysis of plasma enzymes
- 14. Disturbances of non-immunoglobulin plasma proteins
- 15. Disorders of immunoglobulins and paraproteins
- 16. Assessment of acute phase proteins, diagnosis and monitoring of sepsis
- 17. Laboratory findings in inflammatory disorders
- 18. Laboratory diagnosis of malignant hematologic disorders; complete blood count and flow cytometry
- 19. Laboratory diagnostic approaches in anaemias.
- 20. Haemoglobinopathies: disorders of the porphyrin metabolism.
- 21. Laboratory findings in the disorders of iron metabolism.
- 22. Blood coagulation: cellular components (platelets, endothelial cells) and their laboratory analysis.
- 23. Blood coagulation: functional tests (PT, APTT, TT, fibrinogen, D-dimer).
- 24. Laboratory monitoring of anticoagulant therapies.
- 25. Current analytical protocol to detect acute myocardial infarction; international recommendations.
- 26. Laboratory monitoring the therapy of myocardial infarction. Laboratory approaches in chronic heart failure (BNP, proBNP, electrolytes).
- 27. Laboratory diagnostics of the striated muscle diseases.
- 28. Diagnostic criteria of diabetes mellitus (WHO criteria). Laboratory monitoring of patients with diabetic history
- 29. Clinical biochemistry of hypoglycaemia and hyperglycaemia
- 30. Lipids and lipoproteins in the blood plasma
- 31. Laboratory tests that predict hepatic disorders.
- 32. Laboratory diagnostics of alcoholic liver damage. Laboratory tests to assess liver fibrosis
- 33. Disorders of bilirubin metabolism
- 34. Laboratory diagnosis of acute pancreatitis
- 35. Laboratory diagnosis of chronic pancreatitis
- 36. Laboratory diagnosis and monitoring of malignant and inflammatory bowel diseases
- 37. Laboratory diagnosis of acute renal diseases.
- 38. Laboratory diagnosis and monitoring of chronic renal diseases
- 39. Laboratory findings in proteinuria and haematuria
- 40. Laboratory assessment of increased serum uric acid levels
- 41. Laboratory tests of the cerebrospinal fluid and other body fluids.
- 42. Pre-analytical considerations of the hormone tests.
- 43. Clinical biochemistry of the hypothalamus, hypophysis
- 44. Laboratory assessment of the thyroid function
- 45. Clinical biochemistry of the disorders of adrenal medulla/cortex
- 46. Clinical biochemistry of the disorders of the human reproductive system
- 47. The most important non-specific laboratory tests that suggest the presence of malignant diseases.
- 48. Tumor markers and their informational value in the clinical laboratory practice
- 49. Molecular biology applications in the practice of clinical laboratories
- 50. Therapeutic drug monitoring (TDM)
- 51. Toxicology tests in the clinical laboratory